FASN and metabolic dysfunction-associated steatotic liver disease: In order to understand the pharmacological role of PTM and its liposomal nanoparticles in preventing the development of murine NAFLD induced by WD/CCl4, we further studied if PTM could inhibit the expression of FASN in the livers of treated mice.